Mendelian susceptibility to mycobacterial infection in man.

Selective susceptibility to weakly pathogenic mycobacteria, such as bacillus Calmette-Guérin (BCG) vaccine and environmental non-tuberculous mycobacteria (NTM), has long been suspected to be a Mendelian disorder but its molecular basis remained elusive. Recently, mutations in the interferon-gamma receptor ligand-binding chain (IFN gamma R1), interferon-gamma receptor signaling chain (IFN gamma R2), Signal Transducer and Activator of Transcription-1 (STAT-1), interleukin-12 p40 subunit (IL-12 p40), and interleukin-12 receptor beta 1 chain (IL-12R beta 1) genes have been identified in a number of patients with severe BCG or NTM infection. Dominant or recessive alleles causing complete or partial cellular defects have been found to define nine different inheritable disorders. Although genetically distinct, these conditions are immunologically related and highlight the essential role of interferon gamma-mediated immunity in the control of mycobacteria in man. The genetic and immunologic heterogeneity of this syndrome makes accurate diagnosis challenging but vital as decisions about the most appropriate treatment are best taken based on an accurate molecular diagnosis.

[1]  I. N. Brown,et al.  Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? , 1995, The Lancet.

[2]  M. Matsuoka,et al.  Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. , 2001, Blood.

[3]  S. Pestka,et al.  Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. , 2000, The Journal of infectious diseases.

[4]  S. Dorman,et al.  A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.

[5]  J. Casanova,et al.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.

[6]  S. Dorman,et al.  Viral infections in interferon-γ receptor deficiency☆☆☆ , 1999, The Journal of Pediatrics.

[7]  J. Casanova,et al.  Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. , 1999, Experimental hematology.

[8]  S. Holland,et al.  IL-12-Independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection. , 1999, Clinical immunology.

[9]  C. Griscelli,et al.  Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. , 1996, Pediatrics.

[10]  A. Fischer,et al.  A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child. , 1998, American journal of human genetics.

[11]  J. Casanova,et al.  Recurrent Mycobacterium avium Osteomyelitis Associated With a Novel Dominant Interferon Gamma Receptor Mutation , 2001, Pediatrics.

[12]  J. Casanova,et al.  Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. , 1998, Immunology today.

[13]  Steven M. Holland,et al.  Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.

[14]  Capucine Picard,et al.  Impaired Interferon Gamma-Mediated Immunity and Susceptibility to Mycobacterial Infection in Childhood , 2001, Pediatric Research.

[15]  S. Dorman,et al.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.

[16]  R. Döffinger,et al.  Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. , 1998, The Journal of clinical investigation.

[17]  H. Davies,et al.  Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[19]  S. Holland,et al.  Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. , 1996, Journal of immunology.

[20]  S. Dorman,et al.  Abnormal Regulation of Interferon-γ, Interleukin-12, and Tumor Necrosis Factor-α in Human Interferon-γ Receptor 1 Deficiency , 1998 .

[21]  V. McKusick.  Mendelian inheritance in man , 1971 .

[22]  A. Fischer,et al.  Mendelian susceptibility to mycobacterial infection in man. , 1998, Current opinion in immunology.

[23]  J. Casanova,et al.  Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. , 2001, The Pediatric infectious disease journal.

[24]  B. Eley,et al.  Primary Immunodeficiency Diseases in Cape Town , 2000 .

[25]  S. Dorman,et al.  Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. , 1998, The Journal of infectious diseases.

[26]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[27]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[28]  J. Casanova,et al.  Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. , 2001, The Journal of infectious diseases.

[29]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[30]  A. Fischer,et al.  Immunological conditions of children with BCG disseminated infection , 1995, The Lancet.

[31]  R. Döffinger,et al.  IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. , 1999, Current opinion in immunology.

[32]  J. Casanova,et al.  Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  R. Döffinger,et al.  Human interferon‐g‐mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion , 2000, Immunological reviews.

[34]  J. Casanova,et al.  CORRELATION OF GRANULOMA STRUCTURE WITH CLINICAL OUTCOME DEFINES TWO TYPES OF IDIOPATHIC DISSEMINATED BCG INFECTION , 1997, The Journal of pathology.

[35]  A. Arnaiz-Villena,et al.  A Point Mutation in a Domain of Gamma Interferon Receptor 1 Provokes Severe Immunodeficiency , 2001, Clinical Diagnostic Laboratory Immunology.